Dynatrace Stock Extends A 7-Day Losing Streak To A 27% Loss

DTYTD+7.9%SPYYTD+13.0%QQQYTD+12.9%
Analyze DT →

Shares of Dynatrace (DT) have closed lower in each of the last 7 sessions, a cumulative decline of 27.1%. That erased about $5.0 billion from the company’s market value, which now stands at about $13.5 billion. The stock closed at $46.78 on Wednesday, November 4, 28.3% below its 52-week high of $65.25 and 44.6% above its low of $32.36.

Image from Pixabay

 
The Streak Next To The S&P 500

Returns for DT and the S&P 500 over the streak and the periods around it, all ending Wednesday, November 4 and including dividends:
 

Return Period DT S&P 500
1 Day -0.5% 1.6%
7 Days (Current Streak) -27.1% 0.2%
1 Month (21 Trading Days) -23.4% -1.6%
3 Months (63 Trading Days) -4.3% 0.0%
Year To Date 7.9% 13.4%
1 Year (252 Trading Days) -7.3% 13.5%

A Stock-Specific Slide, Or A Market Move?

Over the same 7 trading days, the S&P 500 returned +0.2% including dividends, so the slide is mostly Dynatrace’s own story rather than the market’s. Over the past three months the stock is down 4.3%, a window that includes the streak; over the other 56 sessions of that window it was up 31.3%.

What The Numbers Say About The Slide

On the fundamentals, revenue grew 17.8% over the last twelve months, against a median of 17.9% for S&P 500 Information Technology stocks; its operating margin is 13.6%, versus a median of 21.5%; and the stock trades at 83.2 times trailing earnings against a median of 29.6. The read is mixed.

If the drop has you weighing an entry, resist buying on price alone. Our Buy the Dip screen ranks the marked-down names where growth and cash generation still hold up.

Weakness In One Name Should Be Noise, Not News

For a diversified holder, a streak like this is a data point. For a concentrated one, it is a hole in the plan. The difference is never the stock; it is the portfolio built around it.

Building that portfolio is what the Trefis High Quality (HQ) Portfolio does: roughly 30 businesses with the cash generation and balance-sheet strength to absorb a bad month, selected and rebalanced by rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Make the next streak, in either direction, someone else’s drama.